456 Studies Now Enrolling
Open-trial on the acute treatment of migraine using the Cefaly device
Acute treatment of Migraine using the Cefaly device
| Sponsor: | Cefaly Technologies |
| Enrolling: | Male and Female Patients |
| Study Length: | 1 Days |
| Clinic Visits: | 1 |
| IRB Number: | AAAO9752 |
| Contact: | Denise Chou: 212.305.3937 / cc3825@columbia.edu |
Additional Study Information:
This study plans to learn more about a device called the Cefaly and if it is effective for treating migraine attacks. This device is approved by the Food and Drug Administration (FDA) for the prevention of episodic migraines, but clinical data has not yet been collected on its effectiveness in treating migraine attacks. The Cefaly device works by generating electrical impulses that stimulate certain nerves associated with migraines. A self-adhesive electrode is placed on the forehead. The Cefaly device is worn like a pair of spectacles, and once in position it connects to the electrode. When the button is pressed, the 60-minute course of treatment is delivered automatically. Participation in this study will last 1 hour in the clinic, followed by a brief phone call one hour after participation.
This study is closed
Do You Qualify?
| Have you been diagnosed with episodic or chronic migraine? | Yes | No |
| Have you received treatment with onabotulinum toxin (e.g. Botox, Dysport, Xeomin) to the head in the last four months? | Yes | No |
| Do you have an implanted metal or electrical device in your head? | Yes | No |
| Do you have a cardiac pacemaker or defibrillator? | Yes | No |
| Are your headaches only temporal or occipital headaches? | Yes | No |